With a demand that vaccine boosters be tested against placebos, RFK Jr. puts an old antivaccine claim at the forefront of government health policy.

A late-stage study found Cobenfy wasn’t better than a placebo as an add-on to atypical antipsychotics. Some analysts view the failure as a “significant hit” to the drug’s commercial outlook.

New long-term extension data from the Phase IIb/III QUASAR trial demonstrate that Tremfya (guselkumab) maintains durable ...

Universiti Kebangsaan Malaysia (UKM) created history when it became the first institution in the country to successfully carry out clinical trials of ...

Past research abuses at the CIA-funded Addiction Research Center (ARC) still impact the community today. These abuses ...

What does justice look like when we reflect on the harms caused to Black men and their communities through unethical research ...

SATURDAY, May 3, 2025 (HealthDay News) — Amyotrophic lateral sclerosis (ALS) – known as Lou Gehrig’s Disease based on the ...

Introduction Interstitial lung disease (ILD) patients may develop a progressive phenotype usually characterised by ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from Novavax ...

PROSTATE cancer could be detected early by a simple urine test, according to new research. The breakthrough could potentially ...

Ask questions and weigh the risks before deciding if a clinical trial is right for you.

Federal regulators are asking Novavax NVAX-10.29%decrease; red down pointing triangle to complete an additional randomized clinical trial on its Covid-19 vaccine after previously delaying approval ...